Infection and prevalence of a new segmented flavivirus in the United States
Infection and prevalence of a new segmented flavivirus in the United States
批准号:
10392327
负责人:
Amit Kapoor
金额:
$19.35万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-04-13 至 2023-03-31
关键词:
AfricaAnimal ModelAnimalsBiologicalBiological AssayBlood donorBorrelia burgdorferiCell Culture TechniquesChinaChineseClinical ResearchCodeCommunicable DiseasesComplementary DNACoupledCrimean Hemorrhagic FeverCulicidaeDataDeer MouseDevelopmentDiagnostic ReagentDiseaseDomestic AnimalsEuropeEvolutionExposure toFarmFeverFlavivirusFutureGeneticGenetic VariationGenomeGenomic SegmentGoalsHantavirusHealthHepatitis C virusHumanImmunoprecipitationIndividualInfectionInsectaKnowledgeKosovoLettersLivestockLuciferasesLyme DiseaseMetagenomicsMolecularMusNamesNational Institute of Allergy and Infectious DiseaseNonstructural ProteinNorth AmericaParamyxovirusPathogenesisPatientsPennsylvaniaPeromyscusPhylogenetic AnalysisPoly APolymerasePolyproteinsPowassan virusPrevalencePreventionProteinsProvinceRNARNA VirusesReagentRecording of previous eventsRepliconReportingReverse Transcriptase Polymerase Chain ReactionRodentRouteSamplingSensitivity and SpecificitySerologySerology testSerumSourceSouth AmericaStructural ProteinSystemTestingTicksUnited StatesUnited States National Institutes of HealthVariantVertebratesViralVirusVirus DiseasesWalkingYellow FeverZoonosesanimal coronavirusbasedeep sequencingdiagnostic assaygenome sequencinghelicaseinnovationpreventpublic health relevancereagent testingresearch studyreverse geneticstick bitetick transmissionviromevirus development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary/abstract
Segmented RNA viruses that share phylogenetic relatedness with the prototypic Flaviviruses in their helicase
(NS3) and polymerase (NS5) proteins were recently identified from ticks, mosquitoes, and vertebrates, including
humans suffering with febrile illness. The first Flavi-like segmented viruses (FLSV) were isolated from ticks and
animals in the Jingmen province of China and were thus named Jingmen Tick Virus. Subsequently, highly diverse
FLSV variants were found in Africa, Europe and South America. However, no evidence of FLSV infection has
been reported in North America, including the United States. Moreover, several recent studies that used
metagenomics-based identification of the virome in ticks failed to identify FLSV infection. We were characterizing
the virome of free-ranging mice of the genus Peromyscus, the most common wild mouse species of the North
America, when we identified a highly diverse FLSV in several deer mice from woodlands in Pennsylvania (FLSV-
PN). We acquired partial sequences of all five segments of the FLSV-PN genome and developed serological
assays using Luciferase immunoprecipitation systems. Our serological data suggest that FLSV-PN or its related
variants have a wide host range and infect several economically important farm and domestic animals. Most
importantly, we found strong evidence of FLSV-PN infection in humans with a history of tick-bites and Lyme
disease. The long-term goal of our exploratory/developmental proposal is to define the pathogenesis and health
relevance of FLSV-PN infection. Development of molecular reagents for this new virus will allow us to test our
hypotheses that several genetically diverse FLSV variants are circulating in the United States, and these viruses
are predominantly transmitted by ticks to humans and animals. Specific aim-1 is to acquire the complete
genomes of several diverse FLSV variants. Our preliminary data suggest that FLSV-PN genome is comprised
of five RNA segments that are polyadenylated at the 3’ end. Complete genome sequencing of FLSV-PN is
necessary for the development of sensitive and specific diagnostic assays to study infection prevalence and
disease associations. Specific aim-2 is to determine the infection prevalence of FLSV in humans, domesticated
animals and ticks. These studies will be aided by samples and data available from clinical research studies of
Lyme disease at NIAID, NIH (letter of support attached). The proposed aims represent crucial steps toward
detailed molecular and biological characterization of FLSV-PN, including the development of a reverse genetics
system, replicon systems, cell culture and animal models. Although the health relevance of FLSV infections is
currently not known, the proposed studies will inform this knowledge as well as develop the reagents for
preventing the spread of this new virus and associated diseases, if necessary.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
Development and Validation of Indirect Enzyme-Linked Immunosorbent Assays for Detecting Antibodies to SARS-CoV-2 in Cattle, Swine, and Chicken.
间接酶联免疫吸附剂的开发和验证,用于检测牛,猪和鸡肉中SARS-COV-2的抗体。
DOI:
10.3390/v14071358
发表时间:
2022-06-22
期刊:
Viruses
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.3390/v14122770
发表时间:
2022-12-12
期刊:
Viruses
影响因子:
--
作者:
[Vandegrift KJ, Yon M, Surendran Nair M, Gontu A, Ramasamy S, Amirthalingam S, Neerukonda S, Nissly RH, Chothe SK, Jakka P, LaBella L, Levine N, Rodriguez S, Chen C, Sheersh Boorla V, Stuber T, Boulanger JR, Kotschwar N, Aucoin SG, Simon R, Toal KL, Olsen RJ, Davis JJ, Bold D, Gaudreault NN, Dinali Perera K, Kim Y, Chang KO, Maranas CD, Richt JA, Musser JM, Hudson PJ, Kapur V, Kuchipudi SV]
通讯作者:
Kuchipudi SV
Transmission history of SARS-CoV-2 in humans and white-tailed deer.
人类和白尾鹿的SARS-COV-2传播历史。
DOI:
10.1038/s41598-022-16071-z
发表时间:
2022-07-15
期刊:
SCIENTIFIC REPORTS
影响因子:
4.6
作者:
[Willgert, Katriina, Didelot, Xavier, Surendran-Nair, Meera, Kuchipudi, Suresh, V, Ruden, Rachel M., Yon, Michele, Nissly, Ruth H., Vandegrift, Kurt J., Nelli, Rahul K., Li, Lingling, Jayarao, Bhushan M., Levine, Nicole, Olsen, Randall J., Davis, James J., Musser, James M., Hudson, Peter J., Kapur, Vivek, Conlan, Andrew J. K.]
通讯作者:
Conlan, Andrew J. K.
A sequence-independent approach for attenuating hepaciviruses
-
批准号:10598793
-
项目类别:
-
资助金额:$19.5万
-
财政年份:2022
-
负责人:Amit Kapoor
-
依托单位:
Immune correlates of protection against hepacivirus persistence.
-
批准号:10594475
-
项目类别:
-
资助金额:$61.48万
-
财政年份:2021
-
负责人:Amit Kapoor
-
依托单位:
Immune correlates of protection against hepacivirus persistence.
-
批准号:10378496
-
项目类别:
-
资助金额:$61.48万
-
财政年份:2021
-
负责人:Amit Kapoor
-
依托单位:
Host response and liver disease in a hepatitis C-like virus rat model
-
批准号:10328917
-
项目类别:
-
资助金额:$47.85万
-
财政年份:2018
-
负责人:Amit Kapoor
-
依托单位:
Host response and liver disease in a hepatitis C-like virus rat model
-
批准号:10084805
-
项目类别:
-
资助金额:$48.6万
-
财政年份:2018
-
负责人:Amit Kapoor
-
依托单位:
Novel viruses and viral dynamics in multiple transfusion recipients
-
批准号:9251876
-
项目类别:
-
资助金额:$38.16万
-
财政年份:2016
-
负责人:Amit Kapoor
-
依托单位:
Novel viruses and viral dynamics in multiple transfusion recipients
-
批准号:8697351
-
项目类别:
-
资助金额:$41.99万
-
财政年份:2014
-
负责人:Amit Kapoor
-
依托单位:
Study of rodent HCV-GBV like viruses
-
批准号:8638384
-
项目类别:
-
资助金额:$22.36万
-
财政年份:2014
-
负责人:Amit Kapoor
-
依托单位:
Study of a novel picornavirus genus associated with Acute Flaccid Paralysis
-
批准号:8277184
-
项目类别:
-
资助金额:$19.08万
-
财政年份:2011
-
负责人:Amit Kapoor
-
依托单位:
Study of a novel picornavirus genus associated with Acute Flaccid Paralysis
-
批准号:7896237
-
项目类别:
-
资助金额:$25.69万
-
财政年份:2011
-
负责人:Amit Kapoor
-
依托单位:
Molecular Characterization of Novel Astroviruses
-
批准号:7963656
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2010
-
负责人:Amit Kapoor
-
依托单位:
Molecular Characterization of Novel Astroviruses
-
批准号:8081014
-
项目类别:
-
资助金额:$19.83万
-
财政年份:2010
-
负责人:Amit Kapoor
-
依托单位:
海外基金